A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund ...

In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease.

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Alzheimer’s blood tests are the key to widespread prevention of dementia, experts say. If people can be diagnosed in their doctor’s office, they can more immediately move into preventive care ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.